KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults. RMS exists as two major disease subtypes, oncofusion‐negative RMS (FN‐RMS) and oncofusion‐positive RMS (FP‐RMS). FP‐RMS is characterized by recurrent PAX3/7‐FOXO1 driver oncofusions and is a biologically and...
Main Authors: | Lays M. Sobral, Hannah M. Hicks, Janet K. Parrish, Tyler S. McCann, Joseph Hsieh, Andrew Goodspeed, James C. Costello, Joshua C. Black, Paul Jedlicka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12769 |
Similar Items
-
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma
by: Gabriel Gallo-Oller, et al.
Published: (2024-04-01) -
Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer
by: Yao Gao, et al.
Published: (2024-05-01) -
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
by: Yong Yean Kim, et al.
Published: (2024-02-01) -
FOXO3 polymorphisms influence the risk and prognosis of rhabdomyosarcoma in children
by: Xiaohong Zhang, et al.
Published: (2024-04-01) -
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
by: Shefali Chauhan, et al.
Published: (2024-08-01)